NCT06822725View on ClinicalTrials.gov

The Sinonasal Microbiome

Active, not recruitingOBSERVATIONAL
Enrollment

285

Participants

Timeline

Start Date

January 13, 2025

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2029

Conditions
Sinonasal DisorderChronic Rhinosinusitis (Diagnosis)
Interventions
OTHER

Control Group

normals without allergy, those with perennial allergic rhinitis

PROCEDURE

Chronic rhinosinusitis (CRS) with and without Nasal Polyposis

Those with and without nasal polyps, and those with acute exacerbations

Trial Locations (1)

60637

The University of Chicago, Hyde Park

All Listed Sponsors
lead

University of Chicago

OTHER

NCT06822725 - The Sinonasal Microbiome | Biotech Hunter | Biotech Hunter